Navigation Links
Sundia Receives the Highest Growth Potential Award from Zhangjiang
Date:8/31/2009

SHANGHAI, Aug. 31 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing Service Company in China, announced today that it received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26. The award was announced at the 10th anniversary celebration of "Focus on Zhangjiang Festival" in August. Dr. Tong Xu, Sundia's Vice President for Process Chemistry and GMP Operations, attended the ceremony. "Zhangjiang Hi-Tech Park is China's most successful high technology park which many top high tech start-up companies in China have chosen as their home. I am honored to be here today to receive this award for Sundia," said Dr. Xu.

In August of 1999, Shanghai Municipal Government declared a "Focus on Zhangjiang" strategy to utilize all resources of the city with support from the central Chinese government to make Zhangjiang Park the technology innovation highland of the country. Ten years later, Zhangjiang has become the national biotech & pharmaceutical industry base, which has attracted more than 300 biotech and pharmaceutical companies from all over the world. Sundia Meditech Company, founded in 2004 in Zhangjiang, has kept a high speed for business growth in the past 5 years. For the year 2008, Sundia ranked #52 in Deloitte technology Fast 500 Asia Pacific list, and #16 in Fast 50 China list, with its 928% revenue growth. It was named one of the 50 best companies for investment in 2007 and 2008.

"We are lucky that we made the decision to come to Zhangjiang to start Sundia 5 years ago," said Dr. Wang Xiaochuan, Sundia's Chairman and CEO. "Zhangjiang Hi-Tech Park announced a New Drug Incubation Platform earlier this year to combine venture capitals, intellectual properties, and CRO resources together to support new drug discovery and development programs in the park. Sundia was selected by Zhangjiang as the leading CRO provider to this platform based on our outstanding track record in CRO services. We will try our best to support Zhangjiang Hi-Tech Park to make this platform a success."

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CRO Company Sundia Welcomes New Members to Its Executive Team
2. Finland Biotech Delegation Visits Sundia
3. Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: